LFMDP - LifeMD, Inc. Stock Analysis

Stock Taper

OPPORTUNITY RADAR SCREENER COMPARE ANY 2 STOCKS

LFMDP

LIFEMD, INC.

NASDAQ

$23.31

▲ UP 0.74% (0.17)

KEY STATISTICS

Market Cap$158.95 M

52w High$24.20

52w Low$18.50

Dividend Yield9.34%

FrequencyQuarterly

P/E-718.36

Volume0

Shares Out.6.82M

COMPANY

LEADERSHIP

CHIEF EXECUTIVE

Justin Schreiber

COMPENSATION 2026

Salary$500,000

Stock Awards$0

Incentive Plan Pay$0

All Other Comp.$12,075

Total$777,075

ABOUT

SECTOR

Healthcare

WENT PUBLIC

October 5, 2021

METHOD OF GOING PUBLIC

Reg A+

FULL TIME EMPLOYEES

389

UPCOMING EARNINGS

DateNov 11, 2026

DayWednesday

Rev. Est.$48.87M

NOV

WED

PRICE

$23.31 ▲ UP 0.74% (+$0.17)

About LifeMD, Inc.

https://www.lifemd.com ↗

LifeMD, Inc. is a New York-based telehealth company offering virtual healthcare, prescription meds, and wellness products across various specialties through direct-to-consumer and partner channels.

INDUSTRY

Medical - Healthcare Information Services

A PRODUCT LIFEMD, INC. IS KNOWN FOR

Wegovy® pill via LifeMD's Weight Management Program

LifeMD offers Wegovy® (semaglutide) as the first FDA-approved oral GLP-1 therapy for weight management, expanding their telehealth services and strengthening their position in the growing obesity care market.